Vimarsana
Biggest News Aggregation in the World

Page 13 - Et Cest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Et Cest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Et Cest Today - Breaking & Trending Today

 - Vimarsana News

Kudelski Group / Key word(s): Miscellaneous Assurant Partners with Kudelski IoT’s RecovR Solutions to Offer Theft Recovery and Inventory Management for Automotive Customers 19.09.2023 / 17:45 CET/CEST Partnership with Kudelski IoT will bring enhanced loT management technology to dealership custo...

Nordea Bank Abp: Transaction in Own Shares - Vimarsana News

Nordea Bank Abp: Transaction in Own Shares

Nordea Bank Abp / Key word(s): Transaction in Own Shares Nordea Bank Abp: Transaction in Own Shares 18.09.2023 / 08:25 CET/CEST Nordea Bank Abp: Repurchase of own shares on 15.09.2023 Nordea Bank Abp Stock exchange release - Changes in company's own shares 15.09.2023 at 22.30 EET Nordea Bank Abp...

M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials - Vimarsana News

M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials

EQS Newswire / 18/09/2023 / 11:40 CET/CEST SINGAPORE - Media OutReach - 18 September 2023 - M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System - a revolutionary thera...

EQS-News: ReNeuron Group (RENE): A step forward on the Exosome delivery platform - Vimarsana News

EQS-News: ReNeuron Group (RENE): A step forward on the Exosome delivery platform

EQS-News: / Key word(s): Research Update/Research Update ReNeuron Group (RENE): A step forward on the Exosome delivery platform 18.09.2023 / 08:15 CET/CEST The issuer is solely responsible for the content of this announcement.   London, UK, 18 September 2023   ReNeuron Group (RENE): A step forwa...

EQS-News: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology - Vimarsana News

EQS-News: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

EQS-News: Atriva Therapeutics GmbH / Key word(s): Letter of Intent Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology 18.09.2023 / 15:05 CET/CEST The issuer is solely responsible for the content of this announcement. Atriva Therapeut...